Corgenix Medical Corporation Announces New $1.5 Million Revolving Credit Facility

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTCQB: CONX.OB), a worldwide developer and marketer of diagnostic test kits, today announced that it has closed on a $1.5 million secured revolving line of credit with Bank of the West. The new revolving line of credit provides Corgenix a very favorable interest rate and much greater flexibility than the previous asset-based revolving line of credit. The new credit facility follows the recent move by Corgenix of its primary banking arrangements to Bank of the West.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC